David Matthew Stark - Net Worth and Insider Trading

David Matthew Stark Net Worth

The estimated net worth of David Matthew Stark is at least $41,071 dollars as of 2024-04-28. David Matthew Stark is the Exec. VP Chief Legal Officer of Teva Pharmaceutical Industries Ltd and owns about 2,974 shares of Teva Pharmaceutical Industries Ltd (TEVA) stock worth over $41,071. Details can be seen in David Matthew Stark's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Matthew Stark has not made any transactions after 2023-03-07 and currently still holds the listed stock(s).

Transaction Summary of David Matthew Stark

David Matthew Stark Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Matthew Stark owns 1 companies in total, including Teva Pharmaceutical Industries Ltd (TEVA) .

Click here to see the complete history of David Matthew Stark’s form 4 insider trades.

Insider Ownership Summary of David Matthew Stark

Ticker	Comapny	Transaction Date	Type of Owner
TEVA	Teva Pharmaceutical Industries Ltd	2023-03-07	Exec. VP Chief Legal Officer

David Matthew Stark Latest Holdings Summary

David Matthew Stark currently owns a total of 1 stock. David Matthew Stark owns 2,974 shares of Teva Pharmaceutical Industries Ltd (TEVA) as of March 7, 2023, with a value of $41,071.

Latest Holdings of David Matthew Stark

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TEVA	Teva Pharmaceutical Industries Ltd	2023-03-07	2,974	13.81	41,071

Holding Weightings of David Matthew Stark

David Matthew Stark Form 4 Trading Tracker

According to the SEC Form 4 filings, David Matthew Stark has made a total of 13 transactions in Teva Pharmaceutical Industries Ltd (TEVA) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Teva Pharmaceutical Industries Ltd is the sale of 65,966 shares on March 7, 2023, which brought David Matthew Stark around $629,975.

Insider Trading History of David Matthew Stark

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Matthew Stark Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Matthew Stark Ownership Network

Ownership Network List of David Matthew Stark

No Data

Ownership Network Relation of David Matthew Stark

David Matthew Stark Owned Company Details

What does Teva Pharmaceutical Industries Ltd do?

Who are the key executives at Teva Pharmaceutical Industries Ltd?

David Matthew Stark is the Exec. VP Chief Legal Officer of Teva Pharmaceutical Industries Ltd. Other key executives at Teva Pharmaceutical Industries Ltd include EVP & Chief Financial Officer Eliyahu Sharon Kalif , Exec. VP & European Commercial Richard Daniell , and See "Remarks" Vikki L Conway .

Teva Pharmaceutical Industries Ltd (TEVA) Insider Trades Summary

Over the past 18 months, David Matthew Stark made 2 insider transaction in Teva Pharmaceutical Industries Ltd (TEVA) with a net sale of 129,349. Other recent insider transactions involving Teva Pharmaceutical Industries Ltd (TEVA) include a net sale of 281,251 shares made by Richard Daniell , a net sale of 223,026 shares made by Eric Drape , and a net sale of 137,076 shares made by Sven Dethlefs .

In summary, during the past 3 months, insiders sold 642,750 shares of Teva Pharmaceutical Industries Ltd (TEVA) in total and bought 0 shares, with a net sale of 642,750 shares. During the past 18 months, 1,155,234 shares of Teva Pharmaceutical Industries Ltd (TEVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,155,234 shares.

Teva Pharmaceutical Industries Ltd (TEVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Teva Pharmaceutical Industries Ltd Insider Transactions

No Available Data

David Matthew Stark Mailing Address

Above is the net worth, insider trading, and ownership report for David Matthew Stark. You might contact David Matthew Stark via mailing address: 5 Basel Street, P.o. Box 3190, Petach Tikva L3 4951033.

Discussions on David Matthew Stark

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.